logo-top-r-w
  • HOME
  • ABOUT MORSE
    • The Team
    • Careers
  • SERVICES
    • Our Services
      • Comprehensive Market Access Launch Strategy
      • Market Access Landscape Analysis
      • HTA Planning and Reimbursement Evidence Strategy
      • Negotiation & Stakeholder Engagement Strategy
      • Portfolio & Life Cycle Strategy
      • Expert-Led Training & Customized Workshops
  • REPORTS
    • NEW – Order CRaFT 2026
    • DRD Market Access Trends & Insights
    • Oncology Market Access Trends & Insights
    • Managing Loss of Exclusivity Report
  • NEWS
    • MORSE Signals
    • MORSE Wire
    • Publications
    • What’s New
  • EVENTS
    • Cracking the Code 2.0
  • LINKS
  • CONTACT US
logo-top-r
logo-top-r-w
  • HOME
  • ABOUT MORSE
    • The Team
    • Careers
  • SERVICES
    • Our Services
      • Comprehensive Market Access Launch Strategy
      • Market Access Landscape Analysis
      • HTA Planning and Reimbursement Evidence Strategy
      • Negotiation & Stakeholder Engagement Strategy
      • Portfolio & Life Cycle Strategy
      • Expert-Led Training & Customized Workshops
  • REPORTS
    • NEW – Order CRaFT 2026
    • DRD Market Access Trends & Insights
    • Oncology Market Access Trends & Insights
    • Managing Loss of Exclusivity Report
  • NEWS
    • MORSE Signals
    • MORSE Wire
    • Publications
    • What’s New
  • EVENTS
    • Cracking the Code 2.0
  • LINKS
  • CONTACT US

NEW Canadian Reimbursement Trends and Timelines Report – now available!

September 18, 2019
-
Market Access News, Publications, What's New
-
Posted by MORSE - < 1 min read.

Toronto, September 18, 2019 – MORSE Consulting is pleased to launch the Canadian Reimbursement Trends and Timelines report – a  comprehensive, credible and relevant source of market access intelligence.

The market access pathway in Canada is going through an unprecedented level of change and uncertainty.  This 58-page PowerPoint report is aimed at not only helping market access professionals plan for future launches but can be a valuable education tool for both internal and external stakeholders.

Please click here to learn more about our new report.

 

About the Authors:

MORSE Consulting Inc. is a leader in strategic pharmaceutical market access consulting in Canada. Our team has significant expertise in reimbursement strategy in a wide range of therapeutic areas and has built a reputation for providing meaningful strategic insights. MORSE has established strong, constructive relationships with healthcare stakeholders and a proven track record for delivering impactful results to its clients.

 

Share
Tags
CADTH
CDR
HTA
INESSS
Market Access Strategy
pCODR
pCPA
pCPAO
Public Payers
Reimbursement strategy
TTL
← PREVIOUS POST
Average Time Under pCPA Consideration Below 30 Days for the 3rd Consecutive Month
NEXT POST →
15 Oncology Files either Completed, Initiated or new Under Consideration

Contact Us

MORSE Consulting Inc.

Toronto | Ottawa, Canada

+1-647-717-3179 (Toronto)

+1-613-864-8645 (Ottawa)

info@morseconsulting.ca

CTC Event Vancouver

Carcking the code Vancouver

Pre-order 2026 Report

2025 Canadian Reimbursement and Forecasting Timelines Report

Newsletter – MORSE Signals
Sign up for our free e-mail newsletter service and receive timely and relevant updates related to the emerging developments in the Canadian pharmaceutical reimbursement landscape.

Sign Up
Social
Connect & Follow:
MORSE Consulting Inc. | Deciphering Canadian pharmaceutical market access signals to create reimbursement success.
© 2026 MORSE Consulting Inc. All rights reserved. | Site by Directica Media
NEW Canadian Reimbursement Trends and Timelines Report – now available!
Learn More
Learn More

You're viewing an older edition

The latest CRaFT 2026 report has updated reimbursement data, forecasts, and trends. Get the most current insights.

View the 2026 CRaFT Report → Go to homepage